A comprehensive view of Pregnancy Health. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.
Labcorp to acquire selected assets of BioReference Health from OPKO Health focused on clinical diagnostics and reproductive and women's health in the US outside of New York and New Jersey for US$237.5M; acquisition expected to close in H2 2024
Published:
March 28, 2024
by Laboratory Corp. of America Holdings (LabCorp)
|
FDA grants Fast Track designation to J&J's nipocalimab injectable for FNAIT treatment, a potentially life-threatening condition affecting pregnant women's immune response to fetal platelets; it is the only therapy in clinical development for the disorder
Published:
March 26, 2024
by Janssen Pharmaceutical Companies
|
Janssen spearheads industry-relevant initiatives, from combatting maternal mortality disparities to promoting health equity in clinical research
Published:
March 15, 2024
by Industry Intelligence Inc.
|
Janssen Pharmaceutical Companies Advancing Inclusive Oncology Clinical Trials and Non-Surgical Solutions in Maternal-Fetal Immunology
Published:
February 15, 2024
by Industry Intelligence Inc.
|
Roche Prioritizes Prenatal Screening and Digital Health Innovations to Advance Patient Care and Clinical Research
Published:
February 14, 2024
by Industry Intelligence Inc.
|
Ask us about our Tissue & Hygiene market view